Persistently recurring Mediterranean Kaposi's sarcoma on skin grafts.
Brambilla
L
L
Institute of Dermatology, University of Milan, Italy.
Boneschi
V
V
Zampieri
M
M
Bruognolo
L
L
Fossati
S
S
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006085:Graft Survival; D006801:Humans; D015552:Injections, Intralesional; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D011855:Radiodermatitis / Q000601:surgery; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D012514:Sarcoma, Kaposi / Q000473:pathology* / Q000532:radiotherapy; D012878:Skin Neoplasms / Q000473:pathology* / Q000532:radiotherapy; D016038:Skin Transplantation / Q000473:pathology*; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine